Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for nanotechnology industry professionals · Saturday, April 5, 2025 · 800,484,708 Articles · 3+ Million Readers

Medical Cannabis in Europe | Market Size to hit US$ 6,458 Million by 2028

SHERIDAN, WYOMING, UNITED STATES, March 14, 2023 /EINPresswire.com/ -- According to IMARC Group’s latest report, titled “Europe Medical Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the Europe medical cannabis market size reached US$ 1,743 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 6,458 Million by 2028, exhibiting a growth rate (CAGR) of 22.1% during 2023-2028.

Medical cannabis, also known as medical marijuana, is derived from cannabis plants such as cannabis indica, sativa, and hybrid strains. It contains active ingredients like tetrahydrocannabinol (THC) and cannabidiol (CBD), which are used to treat various medical conditions. It is commonly available in various forms, such as oils, capsules, and edible products. It helps modulate the immune system, promote neuroplasticity, and improve vascular and digestive functioning. As a result, medical cannabis is gaining immense traction in treating chronic pain, anxiety, anorexia, muscle spasms, and nausea across Europe.

Request Free Sample Report: https://www.imarcgroup.com/europe-medical-cannabis-market/requestsample

Market Trends

The Europe medical cannabis market is primarily driven by the rising prevalence of chronic medical conditions such as cancer, arthritis, Alzheimer’s, and migraine. Moreover, the increasing consumption of medical cannabis through inhalation, smoking, oral administration, or topical application, as it provides instant relief to patients by numbing pain receptors, is positively influencing the market growth. Additionally, easy product availability through authorized dispensaries and healthcare centers due to the legalization of medical cannabis in Europe has catalyzed market growth. Other factors, including ongoing research and development (R&D) activities to optimize the use of cannabinoids, surging adoption of medical cannabis for pain management, and significant improvements in healthcare infrastructure, are also anticipated to drive the market further.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3059&flag=C

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

The report has segmented the market on the basis of species, derivative, application, end use, route of administration and country.

Breakup by Species:

Indica
Sativa
Hybrid

Breakup by Derivative:

Cannabidiol (CBD)
Tetrahydrocannabinol (THC)
Others

Breakup by Application:

Cancer
Arthritis
Migraine
Epilepsy
Others

Breakup by End Use:

Pharmaceutical Industry
Research and Development Centres
Others

Breakup by Route of Administration:

Oral Solutions and Capsules
Smoking
Vaporizers
Topicals
Others

Breakup by Country:

Germany
France
United Kingdom
Italy
Spain
Others

Key highlights of the report:

Market Performance (2017-2022)
Market Outlook (2023- 2028)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Related Reports by IMARC Group:

https://www.einpresswire.com/article/601150448/durable-medical-equipment-market-size-trends-industry-growth-and-outlook-2022-27

https://www.einpresswire.com/article/601151496/organ-preservation-market-growth-share-size-industry-trends-and-outlook-2022-27

https://www.einpresswire.com/article/601345983/human-insulin-market-to-grow-at-a-cagr-of-8-6-during-2022-2027-trends-size-share-report

https://www.einpresswire.com/article/616678146/sports-medicine-market-expected-to-reach-us-8-5-billion-by-2028-industry-cagr-of-5-77

https://www.einpresswire.com/article/616678524/ambulance-services-market-expected-to-reach-us-81-9-billion-by-2028-industry-cagr-of-8-89

https://www.einpresswire.com/article/616678756/artificial-organs-market-expected-to-reach-us-31-2-billion-by-2028-industry-cagr-of-8-5

https://www.einpresswire.com/article/616678951/feminine-hygiene-products-market-expected-to-reach-us-35-5-billion-by-2028-industry-cagr-of-4-93

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release